Cerebral glucose utilization measured by positron emission tomography. [1-11C]-D-glucose compared with [2-18F]-2-fluoro-2-deoxy-D-glucose. 1991

G Blomqvist, and S Stone-Elander, and C Halldin, and P E Roland, and C G Swahn, and M Haaparanta, and O Solin, and M Lindqvist, and L Widén
Department of Clinical Neurophysiology, Karolinska Sjukhuset, Stockholm, Sweden.

UI MeSH Term Description Entries
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D003847 Deoxyglucose 2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity. 2-Deoxy-D-glucose,2-Deoxyglucose,2-Desoxy-D-glucose,2 Deoxy D glucose,2 Deoxyglucose,2 Desoxy D glucose
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014055 Tomography, Emission-Computed Tomography using radioactive emissions from injected RADIONUCLIDES and computer ALGORITHMS to reconstruct an image. CAT Scan, Radionuclide,CT Scan, Radionuclide,Computerized Emission Tomography,Radionuclide Tomography, Computed,Scintigraphy, Computed Tomographic,Tomography, Radionuclide-Computed,Computed Tomographic Scintigraphy,Emission-Computed Tomography,Radionuclide Computer-Assisted Tomography,Radionuclide Computerized Tomography,Radionuclide-Computed Tomography,Radionuclide-Emission Computed Tomography,Tomography, Computerized Emission,CAT Scans, Radionuclide,CT Scans, Radionuclide,Computed Radionuclide Tomography,Computed Tomography, Radionuclide-Emission,Computer-Assisted Tomographies, Radionuclide,Computer-Assisted Tomography, Radionuclide,Computerized Tomography, Radionuclide,Emission Computed Tomography,Emission Tomography, Computerized,Radionuclide CAT Scan,Radionuclide CAT Scans,Radionuclide CT Scan,Radionuclide CT Scans,Radionuclide Computed Tomography,Radionuclide Computer Assisted Tomography,Radionuclide Computer-Assisted Tomographies,Radionuclide Emission Computed Tomography,Scan, Radionuclide CAT,Scan, Radionuclide CT,Scans, Radionuclide CAT,Scans, Radionuclide CT,Tomographic Scintigraphy, Computed,Tomographies, Radionuclide Computer-Assisted,Tomography, Computed Radionuclide,Tomography, Emission Computed,Tomography, Radionuclide Computed,Tomography, Radionuclide Computer-Assisted,Tomography, Radionuclide Computerized,Tomography, Radionuclide-Emission Computed
D019788 Fluorodeoxyglucose F18 The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162) 18F Fluorodeoxyglucose,18FDG,2-Fluoro-2-deoxy-D-glucose,2-Fluoro-2-deoxyglucose,Fludeoxyglucose F 18,18F-FDG,Fluorine-18-fluorodeoxyglucose,Fluorodeoxyglucose F 18,2 Fluoro 2 deoxy D glucose,2 Fluoro 2 deoxyglucose,F 18, Fludeoxyglucose,F 18, Fluorodeoxyglucose,F18, Fluorodeoxyglucose,Fluorine 18 fluorodeoxyglucose,Fluorodeoxyglucose, 18F

Related Publications

G Blomqvist, and S Stone-Elander, and C Halldin, and P E Roland, and C G Swahn, and M Haaparanta, and O Solin, and M Lindqvist, and L Widén
July 2002, Molecular imaging and biology,
G Blomqvist, and S Stone-Elander, and C Halldin, and P E Roland, and C G Swahn, and M Haaparanta, and O Solin, and M Lindqvist, and L Widén
May 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
G Blomqvist, and S Stone-Elander, and C Halldin, and P E Roland, and C G Swahn, and M Haaparanta, and O Solin, and M Lindqvist, and L Widén
May 1995, Gut,
G Blomqvist, and S Stone-Elander, and C Halldin, and P E Roland, and C G Swahn, and M Haaparanta, and O Solin, and M Lindqvist, and L Widén
April 1990, Brain research,
G Blomqvist, and S Stone-Elander, and C Halldin, and P E Roland, and C G Swahn, and M Haaparanta, and O Solin, and M Lindqvist, and L Widén
May 2022, Rheumatology (Oxford, England),
G Blomqvist, and S Stone-Elander, and C Halldin, and P E Roland, and C G Swahn, and M Haaparanta, and O Solin, and M Lindqvist, and L Widén
January 1987, Kokyu to junkan. Respiration & circulation,
G Blomqvist, and S Stone-Elander, and C Halldin, and P E Roland, and C G Swahn, and M Haaparanta, and O Solin, and M Lindqvist, and L Widén
March 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
G Blomqvist, and S Stone-Elander, and C Halldin, and P E Roland, and C G Swahn, and M Haaparanta, and O Solin, and M Lindqvist, and L Widén
June 2013, The American journal of the medical sciences,
G Blomqvist, and S Stone-Elander, and C Halldin, and P E Roland, and C G Swahn, and M Haaparanta, and O Solin, and M Lindqvist, and L Widén
February 2007, Annals of nuclear medicine,
G Blomqvist, and S Stone-Elander, and C Halldin, and P E Roland, and C G Swahn, and M Haaparanta, and O Solin, and M Lindqvist, and L Widén
December 1997, Clinics in chest medicine,
Copied contents to your clipboard!